CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND ARE THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL AND HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE...Exclusive License Agreement • February 20th, 2025 • Lomond Therapeutics Holdings, Inc. • Pharmaceutical preparations • California
This Exclusive License Agreement (“Agreement”) is entered into by and between Lomond Therapeutics Operating Corporation, a Delaware corporation, with an address at 8 The Green, Suite 8183, Dover, DE 19901 (“Licensor”), and Viriom, Inc., a Maryland corporation, with an address at 1450 Research Blvd, Rockville, MD 20850 (“Licensee”) and made effective as of February 13, 2025 (“Effective Date”). Licensor and Licensee may hereinafter be individually referred to as a “Party” or collectively as “Parties.”
CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND ARE THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL AND HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE...Exclusive License Agreement • February 20th, 2025 • Lomond Therapeutics Holdings, Inc. • Pharmaceutical preparations • California
This Exclusive License Agreement (“Agreement”) is entered into by and between Lomond Therapeutics Operating Corporation, a Delaware corporation, with an address at 8 The Green, Suite 8183, Dover, DE 19901 (“Licensor”), and Viriom, Inc., a Maryland corporation, with an address at 1450 Research Blvd, Rockville, MD 20850 (“Licensee”) and made effective as of February 13, 2025 (“Effective Date”). Licensor and Licensee may hereinafter be individually referred to as a “Party” or collectively as “Parties.”